Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Schizophr Res. 2021 Feb 23;234:87–93. doi: 10.1016/j.schres.2021.02.001

Table 3.

Odds ratios for C4 haplogroup associations with biomarkers of pathogen exposures and gut dysbioses

C. albicans IgG CMVIgG LBP T. gondii IgG
OR (95th%CI) p OR (95th%CI) p OR (95th%CI) p OR (95th%CI) p
HTZ HMZ HTZ HMZ HTZ HMZ HTZ HMZ
Control
 AL-BS NS NS NS NS NS NS NS NS
 AL-BL NS NS NS NS NS NS NS NS
 BS NS NA 0.52
(0.29–0.95)
0.02
NA NS NA NS NA
 AL NS NA NS NA NS NA NS NA
 AL-AL NS NA NS NA NS NA NS NA
Schizophrenia
 AL-BS NS NS 0.62
(0.44–0.87)
0.001
0.62
(0.43–0.90)
0.001
NS NS NS NS
 AL-BL NS NS NS 1.79
(1.21–2.64)
0.008
0.97
(0.94–1.00)
0.002
NS NS NS
 BS 0.20
(0.05–0.82)
0.0001
NS 1.55
(1.01–2.38)
0.0001
0.0003
(1E-6–0.10)
0.0001
NS 1.18
(1.05–1.33)
0.0001
NS 0.43
(0.26–0.70)
0.001
 AL 2.16
(1.22–3.83)
0.0005
NS 1.56
(1.09–2.24)
0.0001
0.20
(0.06–0.62)
0.0001
NS 1.09
(1.02–1.16)
0.0001
NS 0.33
(0.18–0.60)
0.0001
 AL-AL NS NS NS NS 0.96
(0.92–0.99)
0.0001
NS NS 17.67
(0.98–319.19)
0.0001

OR – odds ratio; CI – confidence interval; p – p-value; HTZ – heterozygote; HMZ – homozygote; NS - not statistically significant at p<0.05; NA - not applicable (due to absence of homozygotes in the control group); CMV - cytomegalovirus

Comparison is HTZ and HMZ relative to absence of haplotype.